Publication | Closed Access

Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes

NanoparticlesNanomedicinePrimary T-lymphocytesEngineeringAntibody-conjugated NanoparticlesImmunologySelective TargetingNano-drug DeliveryTumor TargetingImmunotherapyMedicineRadiation Oncology